This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xopab [2024/08/06 14:16] – [XopAB] rkoebnik | bacteria:t3e:xopab [2025/07/28 15:18] (current) – [Biological function] rkoebnik | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== The Type III Effector XopAB from Xanthomonas ====== | + | ====== The Type III Effector XopAB from //Xanthomonas// ====== | 
| Author: [[https:// | Author: [[https:// | ||
| - | Internal reviewer:\\ | ||
| - | Expert reviewer: **WANTED!** | ||
| Class: XopAB\\ | Class: XopAB\\ | ||
| Line 16: | Line 14: | ||
| === How discovered? === | === How discovered? === | ||
| - | XopAB was discovered via genome-wide screening for effector candidates in //X. oryzae// pv. //oryzae// (//Xoo//) strain MAFF 311018 in accordance with three criteria: i) ORF encoding proteins homologous to effectors of //P. syringae// strains and //X. campestris// | + | XopAB was discovered via genome-wide screening for effector candidates in //X. oryzae// pv. //oryzae// (//Xoo//) strain MAFF 311018 in accordance with three criteria: i) ORF encoding proteins homologous to effectors of //P. syringae// strains and //X. campestris// | 
| === (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
| - | TT3S-dependent translocation of XopAB has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al//., 2009). | + | TT3S-dependent translocation of XopAB has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al.//, 2009). XopAB< | 
| === Regulation === | === Regulation === | ||
| Line 38: | Line 36: | ||
| ===== References ===== | ===== References ===== | ||
| - | Furutani A,Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | + | Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | 
| + | |||
| + | Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL effectors in // | ||
| + | |||
| + | ===== Acknowledgements ===== | ||
| + | |||
| + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||